Skip to content

Ghekiere Pharma

Active Private limited companyfounded 2017active for 9 yearsHavikstraat 8, 8531 HarelbekeKBO/BCE: BE 0672.973.429

Lifetime

9 annual accounts with figures on one time axis
peak of €303,745 in 2025
€303,745▲ 3.9%
lowest -€496 in 2021
€130,334▼ 13.0%
peak of €286,616 in 2024
€148,934▼ 48.0%
€603,843▲ 49.3%
peak of 1 FTE in 2025
1 FTE 
Board1 name since 2017
1 director
Documentsfilings and deeds
01-07-202630 days before the deadline
2025abbreviated format
Dividend €268,016Equity from €286,616 to €148,934Debts from €404,418 to €603,843

Key points

from the 2025 annual accounts

Equity

€148,934 ▼ 48.0%
286,6162024+130,334Profit-268,016Dividend148,9342025

Ghekiere Pharma paid out €268,016 in dividends. That is 206% of the 2025 profit.

Turnover

≈ €1.0m estimated

The accounts state no turnover.

Debts

€603,843 80% of the balance sheet
Financial debts 25%Suppliers 9%Taxes and wages 3%Other 64%

Of this, €452,320 falls due within a year.

Liquidity

1.24 was 2.01 in 2024

Short-term debts rose from €229,199 to €452,320.

Filings

9 annual accounts 1 late
AprilJune31 JulyOctober20202025

The 2024 accounts came 61 days late. The other eight were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as Ghekiere Pharma has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for Ghekiere Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • 186 sharesdeed of 27-03-2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0672973429
Registered office moved from Geluwe to Harelbeke The registered office moved from Dadizelestraat 58, 8940 Geluwe to Havikstraat 8, 8531 Harelbeke (Hulste) · General meeting of 23-11-2022 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by · appointed as manager · published on 27-03-2017 · Gazette deed
First establishment Havikstraat 8, Harelbeke
All 18 events

Comparable companies

same main activity, similar in size and age
Company
Ghekiere Pharma Harelbeke €0.8m €303,745 19.8% 1
STAES - VAN CAMP Grobbendonk €0.7m €346,602 56.8% 0.9
3-FOLIA Ghent €0.7m €288,415 31.1% 0.8
Apotheek Hoegaarden Hoegaarden €0.7m €225,692 3.8% 1
FARMAPHAR Sint-Katelijne-Waver €0.6m €249,436 7.4% 1
Apotheek Helge van de Vijver Bredene €1.0m €346,370 54.5% 1.2
ANAMI Tielt €1.0m €271,261 19.4% 1

These companies have the same main activity as Ghekiere Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €635,000 and €1m, founded between 2015 and 2018.

Official details

Source: KBO
Status
Active since 23-03-2017Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.262.734.3418531 Harelbeke, since 23-03-2017
Financial year end
31 December
Peppol
Reachable since 08-02-2024
Company details

Annual accounts 2025

€752,777▲ 8.9%
Employeeson 31-12-2025
1=
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on Ghekiere Pharma

Ghekiere Pharma files the abbreviated format. That format states no turnover. The gross margin rose from €36,245 in 2017 to €303,745 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Ghekiere Pharma

What is the company number of Ghekiere Pharma?
The company number of Ghekiere Pharma is 0672.973.429. The VAT number is the same number with BE in front: BE 0672.973.429.
Where is Ghekiere Pharma based?
The registered office is at Havikstraat 8, 8531 Harelbeke.Company details
What does Ghekiere Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Ghekiere Pharma?
Ghekiere Pharma is a private limited company (BV).
When was Ghekiere Pharma founded?
Ghekiere Pharma was founded on 23-03-2017.
Is Ghekiere Pharma still active?
Yes, Ghekiere Pharma is an active enterprise in the KBO register.
How many employees does Ghekiere Pharma have?
Ghekiere Pharma had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Ghekiere Pharma fall under?
In its 2025 annual accounts, Ghekiere Pharma states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Ghekiere Pharma?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €303,745 and 42 comparable companies (NACE 477). It probably lies between €820,000 and €1.5m.
Is Ghekiere Pharma profitable?
In financial year 2025, Ghekiere Pharma made a profit of €130,334.
Where can I find the annual accounts of Ghekiere Pharma?
Ghekiere Pharma filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Ghekiere Pharma due?
Ghekiere Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.